News & Careers
Baseimmune closes $4.8m funding round to future-proof vaccines
Q&A - Who are we?
Team of Oxford scientists raise investment to create variant-proof vaccines
Baseimmune and researchers from Imperial College announce co-development of a multi-epitope malaria vaccine
Baseimmune features in UKSpine article about startups from academics
Baseimmune has been selected to be part of KQ Labs, an accelerator at the Francis Crick Institute
If you’d like to know more, contact us.
© 2022 Baseimmune. All rights reserved
Sir Alexander Fleming Building, Imperial College London, London, SW7 2AZ